Average Co-Inventor Count = 3.05
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Glaxo Group Limited (6 from 1,168 patents)
2. Smithkline Beecham Corporation (5 from 2,198 patents)
3. Glaxosmithkline LLC (3 from 356 patents)
14 patents:
1. 8575204 - Nicotinamide derivates useful as P38 inhibitors
2. 8252818 - Nicotinamide derivatives useful as P38 inhibitors
3. 7709506 - Nicotinamide derivatives useful as p38 inhibitors
4. 7626055 - Biphenyl-carboxamide derivatives and their use as p38 kinase inhibitors
5. 7572790 - Biphenyl carboxylic amide p38 kinase inhibitors
6. 7514456 - Nicotinamide derivatives useful as p38 inhibitors
7. 7432289 - 5-Acylamino-1,1'-biphenyl-4-carboxamide derivatives and their use as P38 kinase inhibitors
8. 7396843 - 5'-carbamoyl-1,1′-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors
9. 7309800 - Biphenylcarboxylic amide derivatives as p38 kinase inhibitors
10. 7271289 - Biphenylcarboxylic amide derivatives as p38 kinase inhibitors
11. 7208629 - 5'-Carbamoyl-1,1-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors
12. 7183297 - Biphenyl-derivatives as p38-kinase inhibitors
13. 7151118 - Biphenylcarboxylic amide derivatives as p38-kinase inhibitors
14. 7125898 - Nicotinamide derivatives useful as p38 inhibitors.